Alcon Inc.

NYSE:ALC Stock Report

Market Cap: US$49.8b

Alcon Future Growth

Future criteria checks 1/6

Alcon is forecast to grow earnings and revenue by 11.2% and 6.3% per annum respectively. EPS is expected to grow by 10.8% per annum. Return on equity is forecast to be 8.3% in 3 years.

Key information

11.2%

Earnings growth rate

10.8%

EPS growth rate

Medical Equipment earnings growth17.6%
Revenue growth rate6.3%
Future return on equity8.3%
Analyst coverage

Good

Last updated18 Sep 2024

Recent future growth updates

Recent updates

Alcon Q2: Positive News From Unity VCS/CS And AR-15512

Sep 04

Alcon: Trading At An Undeserved Premium Valuation

Aug 01

Alcon Q1: Robust Product Pipeline Drives Future Growth (Rating Upgrade)

May 14

Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales

Oct 10

Alcon: Lackluster Growth Given Its Valuation

Jul 26

Alcon: The Steady Force Of 'Boring'

Jun 27

Alcon reached $199M settlement with J&J Surgical Vision

Feb 13

Alcon: Case Of Growth Destructive To Value, Reiterate Hold At 24x Earnings

Feb 01

Alcon a buy at Mizuho on 'eyecare dominance'

Dec 22

Alcon Q3 2022 Earnings Preview

Nov 14

Alcon: Looking To Break Downtrend Before Entry

Sep 04

Alcon downgraded to hold at Societe Generale on macro headwinds

Aug 11

Alcon: Revisiting The Investment Thesis

Jun 03

The Recent Pullback Makes Alcon More Attractive

Mar 18

Alcon: Good Quarterly Results, But It Is Still Expensive

Dec 22

Looking At Alcon Through A Different Lens

Sep 11

Alcon Inc. 2021 Q1 - Results - Earnings Call Presentation

May 06

Alcon to acquire U.S. commercialization rights to ophthalmic eye drops Simbrinza from Novartis

Apr 28

Alcon: Global Leader In An Attractive End-Market

Dec 16

Alcon Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 11

Alcon Q3 2020 Earnings Preview

Nov 09

Earnings and Revenue Growth Forecasts

NYSE:ALC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202611,3511,4711,7502,54017
12/31/202510,6631,1801,5062,30121
12/31/20249,9479451,3112,00521
6/30/20249,6361,1021,0861,849N/A
3/31/20249,5621,0487771,644N/A
12/31/20239,4559745351,388N/A
9/30/20239,2744505251,282N/A
6/30/20239,0853623171,157N/A
3/31/20238,8803414801,236N/A
12/31/20228,717335-131,217N/A
9/30/20228,695571-611,259N/A
6/30/20228,657457-171,273N/A
3/31/20228,550460-4061,255N/A
12/31/20218,2913761651,345N/A
9/30/20218,0823323221,397N/A
6/30/20217,8181833071,307N/A
3/31/20216,922-390364949N/A
12/31/20206,833-531256823N/A
9/30/20206,806-717132730N/A
6/30/20206,836-63662677N/A
3/31/20207,525-604275920N/A
12/31/20197,508-656244920N/A
9/30/20197,386-638134800N/A
6/30/20197,280-779178886N/A
3/31/20197,177-362178893N/A
12/31/20187,153-2274281,140N/A
9/30/20187,1231756971,375N/A
12/31/20176,792256N/A1,218N/A
12/31/20166,596-170N/A1,245N/A
12/31/20156,776308N/A1,370N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALC's forecast earnings growth (11.2% per year) is above the savings rate (2.5%).

Earnings vs Market: ALC's earnings (11.2% per year) are forecast to grow slower than the US market (15.2% per year).

High Growth Earnings: ALC's earnings are forecast to grow, but not significantly.

Revenue vs Market: ALC's revenue (6.3% per year) is forecast to grow slower than the US market (8.7% per year).

High Growth Revenue: ALC's revenue (6.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ALC's Return on Equity is forecast to be low in 3 years time (8.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y